- 1) Sampson, H. A., Food allergy. Part 1: immunopathogenesis and clinical disorders. J. Allergy Clin. Immunol., 103, 717–728 (1999).
- 2) Venter, C., Pereira, B., Voigt, K., Grundy, J., Clayton, C. B., Higgins, B., Arshad, S. H., and Dean, T., Prevalence and cumulative incidence of food hypersensitivity in the first 3 years of life. Allergy, 63, 354–359 (2008).
- 3) Tanabe, S., Epitope peptides and immunotherapy. Curr. Protein Pept. Sci., 8, 109–118 (2007).
- 4) Kaminogawa, S., Hachimura, S., Nakajima-Adachi, H., and Totsuka, M., Food allergens and mucosal immune systems with special reference to recognition of food allergens by gut-associated lymphoid tissue. Allergol. Int., 48, 15–23 (1999).
- 5) Knutson, T. W., Bengtsson, U., Dannaeus, A., Ahlstedt, S., and Knutson, L., Effects of luminal antigen on intestinal albumin and hyaluronan permeability and ion transport in atopic patients. J. Allergy Clin. Immunol., 97, 1225–1232 (1996).
- 6) Majamaa, H., and Isolauri, E., Evaluation of the gut mucosal barrier: evidence for increased antigen transfer in children with atopic eczema. J. Allergy Clin. Immunol., 97, 985–990 (1996).
- 7) Kilcawley, K. N., Wilkinson, M. G., and Fox, P. F., Enzyme-modified cheese. Int. Dairy J., 8, 1–10 (1998).
- 8) Korhonen, H., and Pihlanto, A., Bioactive peptides: production and functionality. Int. Dairy J., 16, 945–960 (2006).
- 9) Haileselassie, S. S., Lee, B. H., and Gibbs, B. F., Purification and identification of potentially bioactive peptides from enzyme-modified cheese. J. Dairy Sci., 82, 1612–1617 (1999).
- 10) Tanabe, S., Isobe, N., Miyauchi, E., Kobayashi, S., Suzuki, M., and Oda, M., Identification of a peptide in enzymatic hydrolyzate of cheese that inhibits ovalbumin permeation in Caco-2 cells. J. Agric. Food Chem., 54, 6904–6908 (2006).
- 11) Tanabe, S., Tesaki, S., Watanabe, J., Fukushi, E., Sonoyama, K., and Kawabata, J., Isolation and structural elucidation of a peptide derived from Edam cheese that inhibits β-lactoglobulin transport. J. Dairy Sci., 86, 464–468 (2003).
- 12) Yamada, T., Deitch, E., Specian, R. D., Perry, M. A., Sartor, R. B., and Grisham, M. A., Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation, 17, 641–662 (1993).
- 13) Watanabe, J., Fukumoto, K., Fukushi, E., Sonoyama, K., and Kawabata, J., Isolation of tryptophan as an inhibitor of ovalbumin permeation and analysis of its suppressive effect on oral sensitization. Biosci. Biotechnol. Biochem., 68, 59–65 (2004).
- 14) Ministry of Health, Labour and Welfare of Japan, Analytical methods for nutrients on the standards for nutrition labeling, EISHIN No. 13 (1999).
- 15) Sukhotnik, I., Agam, M., Shamir, R., Shehadeh, N., Lurie, M., Coran, A. G., Shiloni, E., and Mogilner, J., Oral glutamine prevents gut mucosal injury and improves mucosal recovery following lipopolysaccharide endotoxemia in a rat. J. Surg. Res., 143, 379–384 (2007).
- 16) Larson, S. D., Li, J., Chung, D. H., and Evers, B. M., Molecular mechanisms contributing to glutamine-mediated intestinal cell survival. Am. J. Physiol. Gastrointest. Liver Physiol., 293, G1262–1271 (2007).
- 17) Tanabe, S., Watanabe, M., and Arai, S., Production of a high-glutamine oligopeptide fraction from gluten by enzymatic treatment and evaluation of its nutritional effect on the small intestine of rats. J. Food Biochem., 16, 235–248 (1993).
- 18) Wang, Q., Fang, C. H., and Hasselgren, P. O., Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol., 281, R1013–1023 (2001).
- 19) Rainsford, K. D., Stetsko, P. I., Sirko, S. P., and Debski, S., Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease. J. Pharm. Pharmacol., 55, 661–668 (2003).
- 20) Vermeirssen, V., Van Camp, J., and Verstraete, W., Bioavailability of angiotensin I converting enzyme inhibitory peptides. Br. J. Nutr., 92, 357–366 (2004).
- 21) Silva, S. V., and Malcata, F. X., Caseins as source of bioactive peptides. Int. Dairy J., 15, 1–15 (2005).
- 22) Farhadi, A., Banan, A., Fields, J., and Keshavarzian, A., Intestinal barrier: an interface between health and disease. J. Gastroenterol. Hepatol., 18, 479–497 (2003).
- 23) Miyauchi, E., Morita, H., Okuda, J., Sashihara, T., Shimizu, M., and Tanabe, S., Cell wall fraction of Enterococcus hirae ameliorates TNF-α-induced barrier impairment in the human epithelial tight junction. Lett. Appl. Microbiol., 46, 469–476 (2008).
- 24) Tanabe, S., Analysis of food allergen structures and development of foods for allergic patients. Biosci. Biotechnol. Biochem., 72, 649–659 (2008).
Full access
Enzyme-Modified Cheese Exerts Inhibitory Effects on Allergen Permeation in Rats Suffering from Indomethacin-Induced Intestinal Inflammation
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.